|
Evamist® is approved by the FDA for use after menopause to reduce moderate-to-severe
hot flashes.
Estrogens increase the chance of getting cancer of the uterus (womb). Report any
unusual vaginal bleeding right away while you are using Evamist. Vaginal bleeding
after menopause may be a warning sign of cancer of the uterus. Your healthcare provider
should check any unusual vaginal bleeding to find out the cause.
Do not use estrogens with or without progestins to prevent heart disease, heart
attacks, strokes, or dementia. Using estrogens, with or without progestins, may
increase your chance of getting heart attacks, strokes, breast cancer, and blood
clots. Using estrogen, with or without progestins, may increase your risk of dementia,
based on a study of women age 65 years or older. Evamist should not be used if you
have unusual vaginal bleeding; currently have or have had certain cancers, including
cancer of the breast or uterus; had a stroke or heart attack in the past year; currently
have or have had blood clots; currently have or have had liver problems; or think
you may be, or know that you are, pregnant.
The most common side effects that may occur with Evamist are headache, breast tenderness,
the common cold, nipple pain, back pain, nausea, and joint pain.
You and your healthcare provider should talk regularly about whether you still need
treatment with Evamist.
Please see
full prescribing information for Evamist.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
|